Literature DB >> 16924665

Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein.

Lara H El Touny1, Partha P Banerjee.   

Abstract

BACKGROUND: The G2/M cell-cycle arrest is one mechanism by which genistein exerts its anti-proliferative effects, and the proposed underlying causes encompass the transcriptional repression of cyclin B1 and the activation of p21. However, the involvement of upstream kinases Myt-1 and Wee-1 in this arrest remains to be elucidated.
METHODS: Myt-1 and Wee-1 modulation by genistein was examined via Western blot analysis and the effect of their inhibition by siRNA on cyclin B1 levels/localization, cdc2 kinase activity, and cellular proliferation of genistein-treated TRAMP-C2 cells was determined.
RESULTS: The sustained G2/M arrest by genistein in TRAMP-C2 cells is associated with increased phospho-cdc2(Tyr15), decreased cdc2 protein, and cytoplasmic retention of cyclinB1, resulting in decreased cdc2 kinase activity independently of p21. Genistein treatment increased Myt-1 levels and decreased Wee-1 phosphorylation. Downregulation of Myt-1 and Wee-1 by siRNA restored cdc2 levels, its kinase activity, cyclinB1 nuclear localization, and partially restored cell proliferation of genistein-treated cells.
CONCLUSIONS: Myt-1 and Wee-1 rather than p21 are necessary for genistein-induced G2/M arrest in TRAMP-C2 cells and their inhibition partially restores proliferation of TRAMP-C2 cells in the presence of genistein. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924665     DOI: 10.1002/pros.20495

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

Review 1.  Genistein and cancer: current status, challenges, and future directions.

Authors:  Carmela Spagnuolo; Gian Luigi Russo; Ilkay Erdogan Orhan; Solomon Habtemariam; Maria Daglia; Antoni Sureda; Seyed Fazel Nabavi; Kasi Pandima Devi; Monica Rosa Loizzo; Rosa Tundis; Seyed Mohammad Nabavi
Journal:  Adv Nutr       Date:  2015-07-15       Impact factor: 8.701

2.  New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells.

Authors:  Alessandra Rossi; Silvia Schenone; Adriano Angelucci; Martina Cozzi; Valentina Caracciolo; Francesca Pentimalli; Andrew Puca; Biagio Pucci; Raffaele La Montagna; Mauro Bologna; Maurizio Botta; Antonio Giordano
Journal:  FASEB J       Date:  2010-03-30       Impact factor: 5.191

Review 3.  Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals.

Authors:  Subash C Gupta; Ji Hye Kim; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

Review 4.  Genistein: Therapeutic and Preventive Effects, Mechanisms, and Clinical Application in Digestive Tract Tumor.

Authors:  Shenglin Hou
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-29       Impact factor: 2.650

5.  Genistein induces long-term expression of progesterone receptor regardless of estrogen receptor status and improves the prognosis of endometrial cancer patients.

Authors:  Kaori Yoriki; Taisuke Mori; Kohei Aoyama; Yosuke Tarumi; Hisashi Kataoka; Tetsuya Kokabu; Jo Kitawaki
Journal:  Sci Rep       Date:  2022-06-18       Impact factor: 4.996

Review 6.  Multi-targeted therapy of cancer by genistein.

Authors:  Sanjeev Banerjee; Yiwei Li; Zhiwei Wang; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2008-05-19       Impact factor: 8.679

7.  Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle.

Authors:  Ssu-Chia Lin; Shih-Chieh Chueh; Che-Jen Hsiao; Tsia-Kun Li; Tzu-Hsuan Chen; Cho-Hwa Liao; Ping-Chiang Lyu; Jih-Hwa Guh
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

8.  A predictive mathematical model of the DNA damage G2 checkpoint.

Authors:  Kevin J Kesseler; Michael L Blinov; Timothy C Elston; William K Kaufmann; Dennis A Simpson
Journal:  J Theor Biol       Date:  2012-12-22       Impact factor: 2.691

Review 9.  Soy isoflavones and prostate cancer: a review of molecular mechanisms.

Authors:  Abeer M Mahmoud; Wancai Yang; Maarten C Bosland
Journal:  J Steroid Biochem Mol Biol       Date:  2013-12-25       Impact factor: 4.292

10.  TIGAR induces p53-mediated cell-cycle arrest by regulation of RB-E2F1 complex.

Authors:  E Madan; R Gogna; P Kuppusamy; M Bhatt; U Pati; A A Mahdi
Journal:  Br J Cancer       Date:  2012-07-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.